First City Capital Management, Inc. Seagen Inc. Transaction History

First City Capital Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	SELL	$191.51 - $216.16 $19,151 - $21,616	-100 Reduced 4.17%	2,300 $487,000
Q2 2023 Jul 19, 2023	SELL	$187.64 - $206.25 $13,134 - $14,437	-70 Reduced 2.83%	2,400 $461,000
Q3 2022 Oct 24, 2022	SELL	$135.27 - $180.11 $17,585 - $23,414	-130 Reduced 5.0%	2,470 $338,000
Q3 2021 Oct 28, 2021	SELL	$142.45 - $169.82 $14,244 - $16,982	-100 Reduced 3.7%	2,600 $441,000
Q1 2021 May 13, 2021	SELL	$137.51 - $190.8 $13,751 - $19,080	-100 Reduced 3.57%	2,700 $391,000

Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $460,964 - $593,404	2,800 New	2,800 $482,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of First City Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on First City Capital Management, Inc. with notifications on news.